Strategic Partners A/S OZYMF
90.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.09 Day range 0.091
0.09 52-week range 90.00
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 4.84M
- EPS (ttm)
- -2,471.19
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 3.25K
- Open
- 0.091
- Previous close
- 90.00
- Day's range
- 0.09 – 0.091
- 52-week range
- 0.09 – 90.00
2Y 0.00 (0.00%)
News
Orphazyme completes sale of substantially all of its assets and business activities to KemPharm 
Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. 
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today 
Kim Stratton, CEO, resigns from Orphazyme 
CytRx Highlights Orphazyme's Submission of European Marketing Authorisation for Arimoclomol to Treat Niemann-Pick Disease Type C 
Orphazyme closes its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe 
Orphazyme announces U.S. FDA acceptance and Priority Review of New Drug Application for arimoclomol for Niemann-Pick disease Type C 
Stocks That Hit 52-Week Highs On Thursday
Your note
Sign in to keep a note on OZYMF — it syncs with the Stock Master app.